Skip to content

LBRX LBRX Operating Lease Right-of-Use Assets in Other Assets

Operating Lease Right-of-Use Assets in Other Assets at other companies

Alkermes logo
AlkermesALKS
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
Alto Neuroscience logo
Alto NeuroscienceANRO
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
Opko Health logo
Opko HealthOPK
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$888.98M+163%
Enterprise value$571.77M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's operating lease right-of-use assets in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's operating lease right-of-use assets in other assets?
LBRX (LBRX) reported operating lease right-of-use assets in other assets of $2.1M in Q1 2026.